Featuring: publicly traded & venture capital companies on the U.S. (NYSE, NASDAQ, AMEX & OTC: BB) and Canadian (TSX & TSX-V) stock exchanges, Investment & Money Management Ideas.

Press Release - Provectus Pharmaceuticals, Inc. (PVCT-OCT: BB)

We have solved the essential problem that other scientists and companies have not been able to solve; that is to make a cancer specific drug. We have found out how to make it simply, pragmatically and inexpensively; namely, to build it and make a very safe molecule. - Dr. H. Craig Dees, Ph.D. (PVCT) (Interview published April 12, 2007)

The Most Powerful Name In Corporate News and Information.

CURRENT ISSUE  |  COVER ARCHIVES  |   INDEX   |  CONTACT  |  FINANCIALS  |  MARKETING SERVICES   |   HOME PAGE


CEOCFO
-
Members Login

Become A Member!



 

Provectus News

Provectus Among ASCO 2010 Winners
Thursday June 10, 2010

In an article titled "Curtain Closes on ASCO: 2010's Few Winners" appearing on Seeking Alpha, Peter Winter includes Provectus in his list of ASCO 2010 winners. Also discussed is this year's reversal of the "ASCO-effect". In previous years, shares in biotech and pharmaceutical companies have routinely jumped on the release of positive research results at the American Society of Clinical Oncology annual meeting. This year share prices dropped for nearly every presenter, including those who presented very positive news.




    

ceocfointerviews.com does not purchase or make
recommendation on stocks based on the interviews published.